Pharmaceutical marketing has often been viewed through the lens of process and execution – campaigns, timelines, approvals.
Germany's BioNTech on Monday lifted its 2025 revenue guidance after receiving initial payments from its new partner Bristol Myers Squibb in a cancer immunotherapy alliance that seeks to challenge ...
This year, BMS partnered to develop a PD-L1 and VEGF bispecific antibody and has acquired the rights to a new radiopharmaceutical asset.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback